-
公开(公告)号：US06416826B1
公开(公告)日：2002-07-09
申请号：US09371413
申请日：1999-08-10
申请人： Mitsuyo Matsumoto , Tsuyoshi Nozaki , Hideaki Ueda
发明人： Mitsuyo Matsumoto , Tsuyoshi Nozaki , Hideaki Ueda
IPC分类号： C09K1934
CPC分类号： C09K19/3458 , C09K19/0208 , C09K19/42 , C09K19/586 , C09K2019/2092 , C09K2019/3009 , C09K2019/3063 , C09K2019/3065 , Y10T428/10
摘要： A liquid crystal display element includes a cholesteric phase liquid crystal component and a space holding member held within a pair of substrates, wherein at least one of which is transparent. The liquid crystal component is a chiral-nematic liquid crystal material containing a liquid crystal pyrimidine compound having fluorine in the molecule, liquid crystal diphenylacetylene having fluorine in the molecule, and a chiral component. The liquid crystal component may also contain a liquid crystal phenylcyclohexane compound, a liquid crystal cyanobiphenyl compound, and a liquid crystal alkenyl compound. In the present invention, characteristics such as color purity and reflectivity are improved, contrast is increased, and the drive voltage can be reduced by including in the nematic liquid crystal component a liquid crystal pyrimidine compound having fluorine within the molecule, and a liquid crystal diphenylacetylene compound containing fluorine within the molecule.
摘要翻译： 液晶显示元件包括胆甾醇相液晶组件和保持在一对基板内的空间保持构件，其中至少一个是透明的。 液晶成分是含有分子内具有氟的液晶嘧啶化合物，分子中具有氟的液晶二苯基乙炔和手性成分的手性向列型液晶材料。 液晶成分也可以含有液晶苯基环己烷化合物，液晶氰基联苯化合物和液晶烯基化合物。 在本发明中，通过在向列型液晶成分中含有分子内具有氟的液晶嘧啶化合物和液晶二苯基乙炔，能够提高色纯度，反射率等特性，提高对比度，驱动电压降低 在分子内含氟的化合物。
-
32.发明授权Photosensitive member having layer containing fluorine resin particles and resin fine particles and image-forming method and apparatus using same 有权具有含有氟树脂颗粒和树脂细颗粒的层的感光构件和使用它的成像方法和装置公开(公告)号：US06964834B2
公开(公告)日：2005-11-15
申请号：US10437965
申请日：2003-05-15
CPC分类号： G03G15/751 , G03G5/0539 , G03G5/0542 , G03G5/14726
摘要： The present invention relates to an image-forming method and a image-forming device, wherein a specific photosensitive member, an exposing process and a toner are adopted in combination.
摘要翻译： 本发明涉及一种图像形成方法和图像形成装置，其中组合使用特定感光构件，曝光工艺和调色剂。
-
公开(公告)号：US5380745A
公开(公告)日：1995-01-10
申请号：US113358
申请日：1993-08-30
申请人： Katsuhito Uomoto , Tomoko Shomura , Mitsuyo Matsumoto , Masayuki Takagi , Takao Shimizu , Susumu Kiriya
发明人： Katsuhito Uomoto , Tomoko Shomura , Mitsuyo Matsumoto , Masayuki Takagi , Takao Shimizu , Susumu Kiriya
IPC分类号： A61K38/00 , A61K9/00 , A61K31/395 , A61K47/14 , A61K47/44 , A61P33/00 , A61P33/10 , A61K31/40
CPC分类号： A61K9/0019 , A61K31/395 , A61K47/14 , A61K47/44
摘要： A medicinal composition comprising a practically water-insoluble anthelmintic compound such as PF1022 substance, which is a cyclic depsipeptide compound, as an active ingredient, and one or more compounds selected from either or both of nonionic surfactants and fats and oils, optionally together with one or more aqueous solvents, wherein the total content of the additives is adjusted to not less than 1 part by weight, preferably from 5 to 50 parts by weight, based on the anthelmintic compound. This composition makes it possible to elevate water-solubility of the anthelmintic comopund and thus enhance its anthelmintic effect.
摘要翻译： 包含实际上水不溶性的驱肠虫化合物如作为活性成分的环状缩肽化合物的PF1022物质和一种或多种选自非离子表面活性剂和脂肪和油中的一种或两种的化合物，任选地与一种 或更多的含水溶剂，其中基于驱肠化合物将添加剂的总含量调节至不小于1重量份，优选5至50重量份。 该组合物使得可以提高驱虫复合肥料的水溶性，从而增强其驱虫效果。
-
公开(公告)号：US06900469B2
公开(公告)日：2005-05-31
申请号：US09957167
申请日：2001-09-19
IPC分类号： C09K19/02 , G02F1/13 , G02F1/1333 , G02F1/1347 , G02F1/137 , G02F1/139 , H01L29/16
CPC分类号： G02F1/1347 , G02F1/13718
摘要： Disclosed is a liquid crystal display apparatus comprising a pair of substrates and a liquid crystal layer provided between the substrates, the liquid crystal layer containing a liquid crystal composition that exhibits a cholesteric phase. The liquid crystal composition contains a mixture of a chiral material and nematic liquid crystal. The liquid crystal display layer is configured to satisfies the following conditions: a viscosity a [cP] of the liquid crystal composition is in a range from 30 to 150; a dielectric anisotropy b of the liquid crystal composition is in a range from 5 to 50; a thickness c [μm] of the liquid crystal layer is in a range from 3 to 8; and a product of a, b, and c is not less than 3500.
摘要翻译： 公开了一种液晶显示装置，包括一对基板和设置在基板之间的液晶层，该液晶层包含显示胆甾醇相的液晶组合物。 液晶组合物含有手性物质和向列型液晶的混合物。 液晶显示层被配置为满足以下条件：液晶组合物的粘度a [cP]在30至150的范围内; 液晶组合物的介电各向异性b在5〜50的范围内; 液晶层的厚度c [μm]在3〜8的范围内; a，b，c的乘积不小于3500。
-
公开(公告)号：US20050276633A1
公开(公告)日：2005-12-15
申请号：US11104445
申请日：2005-04-13
CPC分类号： G03G15/751 , G03G5/0539 , G03G5/0542 , G03G5/14726
摘要： The present invention relates to an image-forming method and a image-forming device, wherein a specific photosensitive member, an exposing process and a toner are adopted in combination.
摘要翻译： 本发明涉及一种图像形成方法和图像形成装置，其中组合使用特定感光构件，曝光工艺和调色剂。
-
公开(公告)号：US06812977B1
公开(公告)日：2004-11-02
申请号：US09718138
申请日：2000-11-21
申请人： Masako Iwamatsu , Kenji Nishiguchi , Hideaki Ueda , Nobuyuki Kobayashi , Fumie Motoori , Masakazu Okada , Mitsuyo Matsumoto , Akihito Hisamitsu
发明人： Masako Iwamatsu , Kenji Nishiguchi , Hideaki Ueda , Nobuyuki Kobayashi , Fumie Motoori , Masakazu Okada , Mitsuyo Matsumoto , Akihito Hisamitsu
IPC分类号： G02F1133
CPC分类号： G02F1/13473 , G02F1/133502 , G02F1/13718 , G02F2202/28
摘要： A liquid crystal element of a layered type capable of high contrast is provided. For example, in the liquid crystal element of the layered type including liquid crystal layers b, g and r in this order, each of the liquid crystal layers b, g and r is held between electrode formation surfaces of a pair of substrates each provided with an electrode, an insulating film is disposed between the electrodes of the substrates, and at least two liquid crystal layers of the liquid crystal layers b, g and r have the insulating films opposed to the liquid crystal layers and being different in refractive index from each other, respectively.
摘要翻译： 提供了能够提供高对比度的层叠型液晶元件。例如，在液晶层b，g，r的层叠型液晶元件中，各液晶层b，g， r保持在一对基板的电极形成面之间，各自设置有电极，绝缘膜设置在基板的电极之间，液晶层b，g，r的至少两个液晶层具有绝缘 分别与液晶层相对并且折射率彼此不同的膜。
-
公开(公告)号：US07332475B2
公开(公告)日：2008-02-19
申请号：US10565434
申请日：2004-07-22
申请人： Satoru Furukawa , Hideo Kawabe , Hitoshi Ohori , Takao Mukai , Mitsuyo Matsumoto
发明人： Satoru Furukawa , Hideo Kawabe , Hitoshi Ohori , Takao Mukai , Mitsuyo Matsumoto
CPC分类号： C07D311/62 , A23K20/121 , A23K20/147 , A23L33/105 , A23L33/175 , A23V2002/00 , A61K9/0043 , A61K31/353 , A61K38/063 , A61K2300/00 , A23V2250/31 , A23V2250/2116
摘要： The invention provides a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing one or more substances selected from reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin, and a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin.
摘要翻译： 本发明提供了用于预防或治疗属于冠状病毒科或黄病毒科的病毒感染性疾病的组合物，所述组合物含有选自还原型谷胱甘肽或氧化型谷胱甘肽或其药学上可接受的盐和儿茶素的一种或多种物质，以及用于预防 或治疗属于冠状病毒家族或黄病毒科的病毒的感染性疾病，所述组合物含有还原型谷胱甘肽或氧化型谷胱甘肽或其药学上可接受的盐和儿茶素。
-
公开(公告)号：US20060189542A1
公开(公告)日：2006-08-24
申请号：US10565434
申请日：2004-07-22
申请人： Satoru Furukawa , Hideo Kawabe , Hitoshi Ohori , Takao Mukai , Mitsuyo Matsumoto
发明人： Satoru Furukawa , Hideo Kawabe , Hitoshi Ohori , Takao Mukai , Mitsuyo Matsumoto
IPC分类号： A61K38/05
CPC分类号： C07D311/62 , A23K20/121 , A23K20/147 , A23L33/105 , A23L33/175 , A23V2002/00 , A61K9/0043 , A61K31/353 , A61K38/063 , A61K2300/00 , A23V2250/31 , A23V2250/2116
摘要： The invention provides a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing one or more substances selected from reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin, and a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin.
摘要翻译： 本发明提供了用于预防或治疗属于冠状病毒科或黄病毒科的病毒感染性疾病的组合物，所述组合物含有选自还原型谷胱甘肽或氧化型谷胱甘肽或其药学上可接受的盐和儿茶素的一种或多种物质，以及用于预防 或治疗属于冠状病毒家族或黄病毒科的病毒的感染性疾病，所述组合物含有还原型谷胱甘肽或氧化型谷胱甘肽或其药学上可接受的盐和儿茶素。
-
-
-
-
-
-
-
搜索结果
38 条记录 (耗时 0.035 秒)
